News CorMedix Inc.

Equities

CRMD

US21900C3088

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-15 pm EDT			5-day change	1st Jan Change
5.38 ^USD	-7.88%		+13.03%	+43.09%

Apr. 08	Sector Update: Health Care Stocks Decline Late Afternoon	MT
Apr. 08	CorMedix to Supply to DefenCath to Florida-based Dialysis Organization	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)	08:31am	AQ
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference	Apr. 11	AQ
Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 08	MT
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization	Apr. 08	MT
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC	Apr. 08	AQ
CorMedix Inc. Announces Commercial Agreement with ARC Dialysis, LLC	Apr. 08	CI
CorMedix Inc. to Present at the Needham Annual Healthcare Conference	Mar. 27	AQ
Sector Update: Health Care Stocks Ease Wednesday Afternoon	Mar. 13	MT
CorMedix Remains Encouraged on DefenCath Opportunity, RBC Says	Mar. 13	MT
RBC Trims Price Target on CorMedix to $9 From $10, Keeps Outperform Rating, Speculative Risk Qualifier	Mar. 13	MT
Transcript : CorMedix Inc., Q4 2023 Earnings Call, Mar 12, 2024	Mar. 12
CorMedix: Q4 Earnings Snapshot	Mar. 12	AQ
CorMedix Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 12	CI
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	Mar. 12	AQ
CorMedix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
North American Morning Briefing : Inflation Data -2-	Mar. 12	DJ
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024	Mar. 06	AQ
CorMedix Inc. Updates Related to Its Business and Anticipated Launch of DefenCath	Jan. 30	CI
CorMedix Inc. Announces Commercial and Reimbursement Updates	Jan. 30	AQ
CorMedix Inc. Announces Commercial and Operational Updates	Jan. 08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CorMedix Inc.

Equities

CRMD

US21900C3088

Summary

Filters